Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2003
03/20/2003WO2002092042A3 Pharmaceutical and cosmetic compositions against skin aging
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002076411A3 Dermatological agent for the treatment of skin trauma, especially in burn conditions
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002062323A3 Use of mglur5 antagonists for the treatment of pruritic conditions
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002041832A8 Compositions having comfrey and methods for reducing retinoid-induced skin irritation
03/20/2003WO2002040529A3 Diastereomeric peptides and pharmaceutical compositions comprising them
03/20/2003WO2002032412A3 Combination use of acetylcholinesterase inhibitors and gabaa inverse agonists for the treatment of cognitive disorders
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003US20030056233 Induction of psoriasis in animal model; obtain cells, transfer to transgenic rodent, administer cytokine, monitor development of skin disorder
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055275 Prevention of neutrophil recruitment
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055110 Retinoid compounds suited for antibacterial applications
03/20/2003US20030055098 Method of treatment
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055048 Compositions and methods for treating or preventing convulsions or seizures
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055030 Administering 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride for therapy of inflammatory disease or inflammation-associated disorder
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003US20030055014 Administering at least one antiangiogenic nucleic acid molecule in an amount effective to inhibit angiogenesis
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030053973 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
03/20/2003US20030053967 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light
03/20/2003DE20218572U1 Ointment for treating dry, stressed or wounded skin comprises olive oil, sea-buckthorn oil, nigella oil and a perfume oil
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459445A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003CA2457092A1 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003WO2002023992A1 Disinfectant agent
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293497A1 Process for the production of calcium pantothenate
03/19/2003EP1293204A1 Urea-containing gel preparation
03/19/2003EP1293193A1 Use of pantetheine sulfonic acid and/or salts thereof as anti-radical agent
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292610A1 Methods for treating and preventing alopecia
03/19/2003EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292581A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292340A1 Transfection system
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292323A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
03/19/2003EP1292316A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292278A2 Preparations that contain an extract of the plant pistia stratiotes
03/19/2003EP1292277A1 Method for protecting human skin
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
03/19/2003EP1107766B1 Use of lithium gluconate in the preparation of a medicament for treating herpes and seborrheic dermatitis
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1035831B1 Use of carboxylic acid to stabilize or improve epidermal synthesized ceramide
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0918504B1 Use of genistein as a preventive agent against ultraviolet radiation induced skin photodamage and cancer
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003EP0754035B1 Carotenoid agent for inhibiting the conversion of epithelial cells to melanomas
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404387A Cosmetic preparations containing plant extracts
03/19/2003CN1404382A Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403152A Composition for keeping skin's moisture and delaying skin's senility and its prepn
03/19/2003CN1403136A Sore-eliminating medicine powder and its prepn and usage
1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 1065